Join cliexa at ACC.20!

,
American College of Cardiology Conference 2020

The American College of Cardiology (ACC) annual conference hosts colleagues from across the industry to collaborate and facilitate discussions around innovation. The ACC.20 conference takes place on March 28-30 in Chicago. cliexa is excited to announce that we will be attending for the second year in a row! Join cliexa at the ACC.20 conference and schedule a demo with our team here!

 

In addition, cliexa’s CEO & Founder, Mehmet Kazgan, will be participating in an open conversation at ACC.20 about mobile healthcare apps. A popular theme in today’s digital healthcare world is to discuss ways to increase patient engagement within a treatment plan. Therefore, the mobile healthcare industry is moving towards increased communication between patients and physicians through smartphone applications. cliexa’s technology allows for an integrated platform with any EMR that seamlessly connects patients and physicians. Equally important, the app improves the accuracy in patient data collection to utilize in reimbursements.

 

On Monday, March 30 from 9:45am – 11:15am, Mehmet will be participating in this open discussion with two other industry leaders on the topic of mobile healthcare applications. This ‘Knowledge and Networking’ session will be an interesting event to sit in on – and you can add it to your conference itinerary beforehand here. Along with Mehmet, the session leaders include Arash Harzand, MD, MBA, and Francoise Marvel, MD. Also, attendees will have the opportunity to ask questions and lead discussions around this engaging topic during the session.

 

UPDATE 3/9/2020: ACC.20 has been cancelled due to growing coronavirus concerns. Please visit the ACC website for updates and more information.

/by

Patent Allowance for Clinical Data Collection & Processing

, , ,
cliexa's Patent Allowance for Evidence-Based Clinical Data Collection & Processing

Today, we are proud to announce that the United States Patent and Trademark Office has announced the issuance of U.S Patent Number 14,243,549 for cliexa’s “System and Methods for Disease Management.” This patent covers clinical data collection and processing using an “Evidence-Based Data Indexing” (EBDI) model which is the core function of cliexa’s modular digital intake and remote monitoring platform. cliexa enables clinicians to monitor patients’ disease activities and clinical outcomes based on standard and dynamic thresholds within treatment workflows. The platform is tailored by subspecialties and provides automated compliance and billing outputs through cliexa’s proprietary integration services engine.

Disease activity is collected digitally through clinically-validated assessments and stored in a discrete format. This data indexing is generated by a proprietary algorithm referencing connected device data, claims data, and medication adherence or complications. Dynamic stored procedures use a new algorithm every time to update the patient-reported outcome assessments in the database and the application server would process the new or multiple assessments to be enabled in mobile front-end to collect data differently to be able to predict risk factors for specific demographics and multiple chronic disease states. Our computing objects get smarter using a learning algorithm by not only comparing the multiple disease data but also the treatment responses from patients and dynamically changing treatments by their clinicians.

Patients are also presented this dynamic data (e.g. what status their disease at compared to millions of other patients with two or more chronic conditions) to become self-advocates of their care and included IoT data also feeds back to the storage service with smart computing objects to compare existing patient data with others already in the system to give an informed picture to the clinicians.

“We are extremely excited to start 2020 with this recognition by the U.S. Patent Office. As clinical data collection and analysis become more powerful every day for the healthcare industry, cliexa’s model leverages proprietary learning algorithms and AI infrastructure, managing multiple conditions by connecting patients to their providers more effectively,” said Mehmet Kazgan, Founder & CEO of cliexa.

/by

Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool

, , , , , , ,
Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool for Adolescents and Young Adults

cliexa is excited to partner with the University of Northern Colorado (UNC) with a grant from the Department of Health and Human Services’ Office of Adolescent Health that provides nearly one million dollars over the next two years for the implementation of cliexa-OPTIONS, a digital screening intervention tool that fosters earlier identification of high-risk adolescents in a clinical setting. The funding supports independent evaluation including, cost-benefit analysis and randomized controlled trial of the cliexa-OPTIONS risk screening tool and MyPLAN mobile health follow-up. The Principal Investigator for the project at UNC is Dr. William Merchant. He is the evaluation professor in the Applied Statistics and Research Methods program in the College of Education and Behavioral Sciences. 

The cost-benefit analysis assesses cost savings between the cliexa-OPTIONS risk screening against current paper pencil and verbal screenings. Also, the cliexa-OPTIONS risk screening identifies 30- 50% more risk in adolescent populations fostering early identification of adolescents at highest risk for acquiring an STI or experiencing an unplanned pregnancy. Improving quality in clinical workflows for adolescent and young adult populations is timely, given that sexually transmitted infections for young people ages 15 -24 are at epidemic proportions.

Saving time and keeping providers satisfied with new technology in clinical workflows is no simple task. The cost-benefit analysis will also assess the benefits of early identification of adolescents at highest risk for adverse reproductive health outcomes, substance use, mental health, and wellness.

Read the full article at: //www.unco.edu/news/newsroom/releases/million-dollar-grant-digital-screening-intervention-tool.aspx

/by

cliexa Partners with the athenahealth Marketplace Program

, , , , , ,
cliexa is now available in the athenaHealth Marketplace

Today, cliexa Inc., a thriving producer of mobile health care management services, revealed a partnership with athenahealth, Inc.® through athenahealth’s “More Disruption Please” (MDP) Marketplace program. As an MDP partner, our cross-communication platform developed for chronic pain patients and providers, cliexa-EASE, is now immediately available to athenahealth’s network of 100,000+ providers and countless prospective clients. EASE enables patients and clinicians to make intelligent correlations between medication dosage, frequency and heightened or reduced symptoms by leveraging an application that functions as a pain assessment model for chronic pain management with seamless scalable EMR integration via API and global HL7 connectivity.

cliexa provides the ideal pain management application to leverage patient-reported outcomes to improve treatment decisions and patient experience, while also maximizing compliance and reimbursement. cliexa-EASE is designed for chronic pain management, podiatry, and general patient wellness. cliexa-EASE allows providers to gather digitized intake data and customize assessments to correlate data that best adheres to their patient population.

In order to provide physicians with high accuracy metrics, cliexa-EASE uses patient reporting methods on visual body maps, and pain expression in voice, face, and body movements. This allows physicians to view the physical attributes of pain beyond self-reported descriptions which can often be difficult to translate into clinical diagnostics terms. Tracking these markers allows physicians to use patient-reported outcomes to treat the “whole patient.”  One of cliexa’s existing clients, Anderson Podiatry Center, is already seeing the benefits of using the cliexa platform with a custom digital patient intake and screening process, also digital consent forms, integrated to their athenahealth electronic medical record (EMR).

The athenahealth Marketplace partnership opens up a hyperconnected, national network of healthcare professionals providing chronic pain management. With this partnership, the two companies align to provide measurable financial and clinical results for providers. cliexa is a real-time data provider for future medicine and will continue to build on our vision to increase patient-provider engagement and compliance through mobile health solutions.

“We are excited to partner both with athenahealth and Anderson Podiatry Center to deploy cliexa platform into the marketplace as this is the first of many subspecialties we currently have in our portfolio. We are looking forward to implementing other subspecialty applications to the athenahealth marketplace which will strengthen our partnership in healthcare space,” says Mehmet Kazgan, Founder and CEO of cliexa.

Eric Seyler, CEO of Anderson Podiatry Center, says, “The transition to a digital patient intake has given us more opportunities to help our patients than we had envisioned. Our patients have spent less time in the waiting room with more time delegated to their doctor’s visit. The integration is done in real-time which supports our goal to be more efficient with clinic resources while helping to provide the best possible patient experience.”

cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and documentation through real-time integration to athenahealth electronic medical record, which streamlines processes and increases efficiency in population health management.

View our listing here: //marketplace.athenahealth.com/product/cliexa

/by

cliexa invited to the 2019 White House Blue Button Developers Conference

, , , , ,
Image of the White House Lawn

cliexa’s hard work and commitment to improving our country’s healthcare systems has been recognized by the Office of American Innovation (OAI) for our advancements within the industry. The OAI, appointed by President Donald J. Trump, and led by Jared Kushner, has invited cliexa to attend the 2019 White House Blue Button Developers Conference in Washington, D.C. on Tuesday, July 30th at the Eisenhower Executive Office Building. We are humbled and honored to receive this invitation. We are looking forward to connecting and potentially collaborating with policymakers, technologists, and medical experts to advance the sharing of medical information through mobile technology.

We are one of the few technology vendors who have successfully enabled the Center for Medicare and Medicaid’s (CMS) Blue Button 2.0 API into our software platforms. According to CMS’s website, the Blue Button 2.0 API is a “developer-friendly, standards-based API that enables Medicare beneficiaries to connect their claims data to the applications, services and research programs they trust.” This API enables patients to sync their Medicare accounts to our applications and bi-directionally share the information, specifically claims data, to their providers, and care teams.

With this information, there are a variety of potential outcomes from leveraging this data, including streamlined documentation and the secure exchange of patient information which can lead to uncovering new insights about patients’ health status and increasing time for face-to-face interactions between patient and provider.

Image of cliexa-EASE with CMS' Blue Button 2.0 API enabled

Our first use case for this API was in our application, cliexa-EASE, designed for the Department of Health and Human Services‘ Agency for Healthcare Research and Quality‘s Step-Up App Challenge. With this build, we were selected as one of the three winners of this challenge. The goal of the challenge was to develop an application that simplifies the process of collecting, interpreting, aggregating and sharing patient-reported outcomes (PRO) data related to physical function outcomes. Using the Blue Button 2.0 API, patients could connect Medicare accounts to our platform and share their claims data directly to the health systems’ electronic medical record system. Other functionalities including the connection and aggregation of data from IoT and wearable devices, electronic medical record systems paired with custom, mobile clinical assessments.

To learn more about the Blue Button 2.0 API, and the Blue Button Developers Conference, visit //bluebutton.cms.gov/

/by